Non-Medical Use of Prescription Stimulants and Illicit Use of Stimulants for Cognitive Enhancement in Pupils and Students in Germany

 

 Buy Article Permissions and Reprints

Abstract

Introduction: The aim of this study was to assess for the first time the prevalence and factors associated with stimulant use exclusively for cognitive enhancement among pupils and university students in Germany.

Methods: A sample of 1 035 pupils (vocational and grammar schools) in small and big cities and 512 university students of 3 Departments (Medicine, Pharmacy, Economics) completed a questionnaire regarding knowledge and use of stimulants for cognitive enhancement and factors associated with their use.

Results: Lifetime prevalence for use of prescription stimulants (methylphenidate, amphetamines) for cognitive enhancement in pupils was 1.55% and in students 0.78%. Last-year and last-month prevalence rates were significantly lower. 2.42% of pupils and 2.93% of students reported lifetime illicit use of stimulants (amphetamines, cocaine, ecstasy) for cognitive enhancement with lower last-year and last-month rates. Prevalence was higher in male pupils, pupils from vocational schools and pupils with bad marks.

Discussion: The illicit use of stimulants for cognitive enhancement is significantly higher than non-medical use of prescription stimulants among pupils and students. Stimulant use is determined by gender, school type, and school marks. The potential risks associated with stimulant use require early awareness and intervention strategies.

References

• 1 Babcock Q, Byrne T. Student perceptions of methylphenidate abuse at a public liberal arts college.  J Am Coll Health. 2000;  49 143-145
  CrossrefPubMedGoogle Scholar
• 2 Bright GM. Abuse of medications employed for the treatment of ADHD: results from a large-scale community survey.  Medscape J Med. 2008;  10 111
  Google Scholar
• 3 Cakic V. Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology.  J Med Ethics. 2009;  35 611-615
  Google Scholar
• 4 Cashin JR, Presley CA, Meilman PW. Alcohol use in the Greek system: follow the leader?.  J Stud Alcohol. 1998;  59 63-70
  PubMedGoogle Scholar
• 5 Farah MJ. Emerging ethical issues in neuroscience.  Nat Neurosci. 2002;  5 1123-1129
  CrossrefPubMedGoogle Scholar
• 6 Farah MJ, Illes J, Cook-Deegan R. et al . Neurocognitive enhancement: what can we do and what should we do?.  Nat Rev Neurosci. 2004;  5 421-425
  Google Scholar
• 7 Franke AG, Lieb K. Missbrauch von Psychopharmaka zum Hirndoping. CME-Artikel.  InFo Neurologie & Psychiatrie. 2009;  11 42-51
  PubMedGoogle Scholar
• 8 Franke AG, Lieb K. Pharmacological neuroenhancement and brain doping: Chances and risks.  Bundesgesundheitsblatt. (in press)
  PubMedGoogle Scholar
• 9 Giles J. Alertness drug arouses fears about ‘lifestyle’ misuse.  Nature. 2005;  436 1076
  CrossrefPubMedGoogle Scholar
• 10 Greely H, Sahakian B, Harris J. et al . Towards responsible use of cognitive-enhancing drugs by the healthy.  Nature. 2008;  456 702-705
  Google Scholar
• 11 Hall KM, Irwin MM, Bowman KA. et al . Illicit use of prescribed stimulant medication among college students.  J Am Coll Health. 2005;  53 167-174
  CrossrefPubMedGoogle Scholar
• 12 Hechtman L, Greenfield B. Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome.  Paediatr Drugs. 2003;  5 787-794
  PubMedGoogle Scholar
• 13 Kaloyanides KB, McCabe SE, Cranford JA. et al . Prevalence of illicit use and abuse of prescription stimulants, alcohol, and other drugs among college students: relationship with age at initiation of prescription stimulants.  Pharmacotherapy. 2007;  27 666-674
  CrossrefPubMedGoogle Scholar
• 14 Killgore WD, Kahn-Greene ET, Grugle NL. et al . Sustaining executive functions during sleep deprivation: A comparison of caffeine, dextroamphetamine, and modafinil.  Sleep. 2009;  32 205-216
  Google Scholar
• 15 Killgore WD, Rupp TL, Grugle NL. et al . Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness.  J Sleep Res. 2008;  17 309-321
  CrossrefPubMedGoogle Scholar
• 16 Maher B. Poll results: look who's doping.  Nature. 2008;  452 674-675
  Google Scholar
• 17 McCabe SE, Knight JR, Teter CJ. et al . Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey.  Addiction. 2005;  100 96-106
  CrossrefPubMedGoogle Scholar
• 18 McCabe SE, Teter CJ, Boyd CJ. Medical use, illicit use and diversion of prescription stimulant medication.  J Psychoactive Drugs. 2006;  38 43-56
  CrossrefPubMedGoogle Scholar
• 19 McCabe SE, Teter CJ, Boyd CJ. The use, misuse and diversion of prescription stimulants among middle and high school students.  Subst Use Misuse. 2004;  39 1095-1116
  CrossrefPubMedGoogle Scholar
• 20 Mitler MM, Harsh J, Hirshkowitz M. et al . Long-term efficacy and safety of modafinil (PROVIGIL^®) for the treatment of excessive daytime sleepiness associated with narcolepsy.  Sleep Med. 2000;  1 231-243
  CrossrefPubMedGoogle Scholar
• 21 Poulin C. From attention-deficit/hyperactivity disorder to medical stimulant use to the diversion of prescribed stimulants to non-medical stimulant use: connecting the dots.  Addiction. 2007;  102 740-751
  CrossrefPubMedGoogle Scholar
• 22 Racine E, Forlini C. Expectations regarding cognitive enhancement create substantial challenges.  J Med Ethics. 2009;  35 469-470
  CrossrefPubMedGoogle Scholar
• 23 Strote J, Lee JE, Wechsler H. Increasing MDMA use among college students: results of a national survey.  J Adolesc Health. 2002;  30 64-72
  CrossrefPubMedGoogle Scholar
• 24 Deutsche Hauptstelle für Suchtfragen e.V. Jahrbuch Sucht 2009 . 2009;  Neuland Verlag, Geesthacht
  PubMed
• 25 Teter CJ, McCabe SE, Boyd CJ. et al . Illicit methylphenidate use in an undergraduate student sample: prevalence and risk factors.  Pharmacotherapy. 2003;  23 609-617
  CrossrefPubMedGoogle Scholar
• 26 Teter CJ, McCabe SE, Cranford JA. et al . Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample.  J Am Coll Health. 2005;  53 253-262
  CrossrefPubMedGoogle Scholar
• 27 Teter CJ, McCabe SE, LaGrange K. et al . Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration.  Pharmacotherapy. 2006;  26 1501-1510
  CrossrefPubMedGoogle Scholar
• 28 Upadhyaya HP, Rose K, Wang W. et al . Attention-deficit/hyperactivity disorder, medication treatment, and substance use patterns among adolescents and young adults.  J Child Adolesc Psychopharmacol. 2005;  15 799-809
  CrossrefPubMedGoogle Scholar
• 29 Wesensten NJ, Killgore WD, Balkin TJ. Performance and alertness effects of caffeine, dextroamphetamine, and modafinil during sleep deprivation.  J Sleep Res. 2005;  14 255-266
  Google Scholar
• 30 Wilens TE, Adler LA, Adams J. et al . Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature.  J Am Acad Child Adolesc Psychiatry. 2008;  47 21-31
  Google Scholar
• 31 Wilens TE, Gignac M, Swezey A. et al . Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications.  J Am Acad Child Adolesc Psychiatry. 2006;  45 408-414
  CrossrefPubMedGoogle Scholar
• 32 Wu LT, Schlenger WE. Psychostimulant dependence in a community sample.  Subst Use Misuse. 2003;  38 221-248
  CrossrefPubMedGoogle Scholar

Correspondence

Dr. Dr. A. G. FrankeM.A. 

Department of Psychiatry and

Psychotherapy

University Medical Center

Mainz

Untere Zahlbacher Straße 8

55131 Mainz

Germany

Phone: +49/6131/17 2920

Fax: +49/6131/17 6690

Email: afranke@uni-mainz.de